We will explore the full spectrum of market assessment, regulatory validation, and development planning required to bring innovative animal health products to market. We will examine how robust market analysis drives investor interest and attracts strategic corporate partners, while also serving as the foundation for confirming regulatory pathways and requirements.
Building on this foundation, we will outline strategies and tactics for regulatory approval, the creation of targeted development plans, and approaches to expedite product positioning and launch.
Additional insights will be shared on co-development opportunities with corporate animal health companies, offering participants a clear roadmap from concept to commercialization.
Paul Dick
Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.
While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.
His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.
Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.
In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).